单孔机器人右半结肠完整结肠系膜切除术的技术与肿瘤学可行性
BACKGROUND: Single-incision robotic surgery (SIRS) using the da Vinci SP system (dVSP) offers advantages such as improved cosmesis, reduced invasiveness, and technical precision in colorectal surgery.…
要点
- 单孔机器人右半结肠CME未发生中转开腹或术中并发症。
- 平均清扫淋巴结45.5枚,所有病例切缘阴性。
- 恶性肿瘤患者5年总生存率93.3%,无病生存率93.7%。
核心结论
- 采用da Vinci SP系统的单孔机器人右半结肠切除术技术可行且安全,围手术期结果良好,基于长期结局显示肿瘤学安全性。
主要发现
- 平均手术时间282.2±54.5分钟,估计失血量65.9±44.9毫升。
- 67.3%的病例行体内吻合,平均脐部切口长度3.7±0.9厘米。
- 术后并发症发生率19.2%,再入院率5.8%。
- 病理结果显示23.9%的患者为III期,平均清扫淋巴结45.5±25.0枚,所有病例切缘阴性。
- 中位随访30.0个月(范围5.0-72.0),恶性肿瘤患者5年总生存率93.3%,无病生存率93.7%。
临床怎么用
- 对于右侧结肠肿瘤,可考虑采用da Vinci SP系统行单孔机器人完整结肠系膜切除术,需注意其围手术期结果和肿瘤学结局。
局限性
- 回顾性研究设计,样本量有限,随访时间范围较宽,需进一步前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Single-incision robotic surgery (SIRS) using the da Vinci SP system (dVSP) offers advantages such as improved cosmesis, reduced invasiveness, and technical precision in colorectal surgery. However, real-world data regarding the technical feasibility and oncologic outcomes of dVSP-based complete mesocolic excision (CME) with central vascular ligation (CVL) for right-sided colon neoplasms remain limited. METHODS: We retrospectively reviewed the medical records of patients who underwent single-incision robotic right colectomy for colon cancer or precancerous lesions with dVSP between July 2019 and April 2025. Demographic characteristics, perioperative outcomes, pathologic results, and survival outcomes were analyzed. RESULTS: Fifty-two patients were included. Mean operation time and estimated blood loss were 282.2 ± 54.5 min and 65.9 ± 44.9 ml, respectively. Intracorporeal anastomosis was performed in 67.3% of cases, and the mean umbilical wound length was 3.7 ± 0.9 cm. There were no conversions to open surgery or intraoperative complications. The mean time to first flatus was 2.6 ± 0.7 days, and patients began a soft diet at 3.2 ± 0.6 days postoperatively, with a mean hospital stay of 7.0 ± 2.4 days. Postoperative complications occurred in 19.2% and readmission rate was 5.8%. Pathologic outcomes showed 23.9% of patients with stage III disease, the mean number of harvested lymph nodes was 45.5 ± 25.0, and all cases had negative resection margins. One patient (1.9%) developed local recurrence at 8 months postoperatively, resulting in disease-specific mortality, and another patient (1.9%) developed multiple lung metastases at 9 months and is currently receiving palliative chemotherapy. Among patients with malignant tumors, 5-year overall survival and disease-free survival rates were 93.3% and 93.7%, respectively. The median follow-up period was 30.0 (range 5.0-72.0) months. CONCLUSION: Single-incision robotic right colectomy using the dVSP is technically feasible and safe approach, offering favorable perioperative results and has proven oncologic safety based on long-term outcomes.
引用
- Jo MH, Kim HS, Chung SS, et al. Single-incision robotic complete mesocolic excision for right-sided colon neoplasms: technical and oncologic feasibility. Surg Endosc. 2026. PMID: 41703038. doi:10.1007/s00464-026-12664-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。